Pregabalin (Lyrica)

Pregabalin, sold under the brand name Lyrica, is a prescription medication used to treat nerve pain and other conditions, making it an important option for those suffering from chronic discomfort.

Indexed studies indicate that pregabalin effectively manages various types of pain, including fibromyalgia and sciatica. It works by binding to calcium channels in the brain and spinal cord, reducing the release of neurotransmitters involved in pain signaling. While combined use with gabapentin can sometimes enhance pain control, this approach requires careful consideration due to potential side effects.

Pregabalin connects strongly to conditions like fibromyalgia and neuropathic pain, as well as to other medications used for pain management such as gabapentin. Understanding its mechanism of action provides insight into how it differs from traditional pain relievers.

Evidence quality varies across studies, with some focusing more on specific types of pain than others, thus limiting the generalizability of findings to all pain conditions.

Sources

• Is there a role for combined use of gabapentin and pregabalin in pain control? Too good to be true? (PMID:29023146)
• Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. (PMID:17126531)
• Pregabalin (Lyrica) for Acute Fibromyalgia Pain. (PMID:29763265)
• [[Pregabalin (Lyrica)].](https://pubmed.ncbi.nlm.nih.gov/23905403/) (PMID:23905403)
• A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain. (PMID:34637958)
• Discovery and Development of Pregabalin (Lyrica): The Role of Public Funding. (PMID:34493615)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._